| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |